Carriers for CFTR mutations have been estimated as up to 1.9% of asthma in Asians and 1.6% of asthma in Europeans, indicating the significant CF heterozygosity’s contribution to asthma cases among Asian and European populations, according to meta-analysis findings [11]. This evidence concerns the gene CFTR and asthma.